INC Research Appoints David Provost as Vice President, Late Phase Services.

RALEIGH, N.C. -- INC Research, a therapeutically-focused contract research organization (CRO) with a trusted process for delivering reliable results, announced that David Provost has joined the Late Phase Services team as vice president. In this position, Provost will be responsible for managing the operational unit, as well as for providing strategic consulting to customers regarding the design and implementation of their global late phase programs. The group will initially focus on Phase IV trials, patient registries, observational outcomes studies and safety surveillance studies.

"Due to increased regulatory scrutiny, the number of Phase IV studies will continue to increase," said Alistair Macdonald, senior vice president, Global Data Services. "David's focused background in critical late phase areas is a perfect match for us as we continually strive to enhance the high standard of Late Phase Services that we deliver to our customers. We are thrilled to have David join our team."

"I'm excited to be joining the INC Research team," commented Provost. "The company's continuing investments in innovative processes and technologies will help ensure that we are always able to provide our customers with strategic solutions for their late phase research and post-approval marketing support needs." Provost brings deep expertise in program design and implementation strategies for post-approval services to INC Research's Late Phase Services, including late stage trials, risk management, patient adherence and post-approval safety.

Prior to joining INC Research, Provost was senior executive director, Post-Approval Strategic Operations for PPD. Prior to this position, he was a central figure in the launch of the company's registries and observational studies group and served as its executive director. During his tenure, Provost also served as executive director, Clinical Communications and Informatics within the company's peri- and post-approval operations team and director, Informatics within its health outcomes group. Prior to joining PPD, Provost was director, Software Development for Emron, Inc. a healthcare research and communications company. Provost has a bachelor's degree in psychology from The Johns Hopkins University.

Specializing in adult and pediatric trials in Phases IIIb and IV, INC Research's Late Phase Services team has a proven track record of designing and completing targeted late phase research programs. The company's pharmacovigilance and post marketing product safety services will address the unique demands in this area.

With its Trusted Process(TM) method of delivering predictably dependable trial outcomes, INC Research is able to proactively address the key regulatory issues that are critical to their customer's success. Furthermore, its extensive network of physicians and clinical sites support accelerated timelines.

About INC Research([R])

INC Research is a therapeutically-focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric trials. The company's Trusted Process[TM] methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, and now in 24 locations in 32 countries worldwide. For more information please visit www.incresearch.com.